RESEARCH / PARTICIPATIONBack to the library
← Find a study
Recruiting · registry status

Distinguishing Parkinson’s from other causes of dementia

Researchers compare symptoms, thinking tests, sleep recordings and brain scans in Parkinson’s, Alzheimer’s disease and Lewy body dementia.

Learning by observing or collecting information · Study reference: NCT03019757

Plain-language introduction written with AI from the registry; not independently checked by a clinician. Read the original details below ↓

This registry record was last updated over six months ago, or its update date is missing. Recruitment may have changed. Confirm with the team before making plans.

Open the official registry record ↗

Follow this study

Looking for volunteers

Start (reported actual date)
2018-08-30
Main measurements finished (planned)
2026-12
Study finished (planned)
2026-12

Planned dates can move. A study finishing does not tell us when a paper will be published.

No results summary has been confirmed in the registry records we imported. See connected papers below; we keep checking after recruitment ends.

Changes we have recorded
  • 2026-10-11 — recruiting

These are dates we observed a change, not necessarily the dates it happened.

Papers connected to this study

No connected paper has been found yet. The tracker checks the growing library for study identifiers and registry-linked publications.

Who can join?

Age 18 years and over · Does not accept healthy volunteers

These are starting points, not the full rules. The research team can tell you whether the study is right for your situation.

Read all the rules for taking part

Sex eligibility reported by registry: all

Inclusion Criteria: * Subjects must meet the standard clinical criteria of the syndromes of interest * All subjects must have enough cognitive abilities to complete study procedures, which will be operationally defined as having a Mini Mental State Examination (MMSE) score greater or equal to 10. * Subjects must be on stable cognitive and psychoactive medication regimen for the preceding four weeks of enrollment. * Subjects must have a responsible study partner that either lives with them or is in regular contact with them at least 4 out of 7 days per week. * Subjects must have visual and auditory acuity adequate for testing. Exclusion Criteria: * Any other condition (other than the primary diagnosis), which in the opinion of the investigators might contribute to the syndrome of dementia or complicate its assessment. * active medical disorder that could preclude participation in this protocol * Women who are pregnant or are breast feeding * severe renal impairment as defined by glomerular filtration rate (GFR) less than 30 (may have increased radiation exposure with the DaTscan). * Subjects in whom English is not the 1st language * Subjects with educational level less than 12 years * Subjects who have ever participated in an experimental study with an amyloid targeting agent unless it can be documented that the subject received only placebo during the course of the trial.
Full study name & original research details

Official study title

Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

Original description

The study is designed to characterize the clinical, neuropsychological, polysomnographic, and neuroimaging findings among subjects with Alzheimer's disease, Lewy Body dementia, and Parkinsons' Disease.

Further description from the registry

The study will use structural and functional MRIs, daTscans, fluorodeoxyglucose (FDG) PET scans, Amyvid PET scans, polysomnographs, neuropsychological testing, cerebrospinal fluid in willing participants to distinguish between a diagnosis of Alzheimer's disease, Lewy Body dementia, and Parkinson's Disease. All subjects will have a clinical evaluation, physical examination including vital signs and orthostatic blood pressures and pulses, neurological examination including UPDRS evaluation, genetic blood sample collection, neuropsychological testing, polysomnogram, and neuroimaging. The study partner will also be interviewed for completion of all of the behavioral and functional measures.

Conditions reported: Alzheimer's Disease; Lewy Body Dementia; Parkinson's Disease

Registry records for this study

Records are joined using registration identifiers. Titles alone do not establish that two studies are the same.

Study type
Observational
Interventions
DaTscan; F18-AV-45; FDG-PET; APOE genotype; Polysomnogram; Clinical Assessment
Phases
Not reported
Sponsor
Douglas Scharre
Start date reported by registry
2018-08-30 (actual)

Registry updated: 2025-03-30 · Status last verified by the registry submitter: 2025-03

Registry records retrieved 2026-10-13 (UTC). Individual records may have older updates. Recruitment and eligibility must be confirmed with the study team.

Contact the research team

Public study contacts supplied to the registry. Ask whether recruitment is still open and what participation involves.

Jennifer Icenhour · 614-293-6882 · jennifer.icenhour@osumc.edu

Study locations

Site status can differ from overall study status. “Status not reported” means local availability needs confirmation. Remote participation and travel arrangements must be checked with the team.

The Ohio State University

Columbus, Ohio, United States

Recruiting

Jennifer Icenhour · 614-293-6882 · jennifer.icenhour@osumc.edu

The original descriptions and participation rules come from the registry. Participation is voluntary and does not guarantee benefit.